DK0917879T3 - Forbedret fremgangsmåde til stabilisering af proteiner - Google Patents
Forbedret fremgangsmåde til stabilisering af proteinerInfo
- Publication number
- DK0917879T3 DK0917879T3 DK98121684T DK98121684T DK0917879T3 DK 0917879 T3 DK0917879 T3 DK 0917879T3 DK 98121684 T DK98121684 T DK 98121684T DK 98121684 T DK98121684 T DK 98121684T DK 0917879 T3 DK0917879 T3 DK 0917879T3
- Authority
- DK
- Denmark
- Prior art keywords
- stabilization method
- protein stabilization
- improved protein
- improved
- stabilization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97120528 | 1997-11-22 | ||
EP98102846 | 1998-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0917879T3 true DK0917879T3 (da) | 2002-11-04 |
Family
ID=26145913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98121684T DK0917879T3 (da) | 1997-11-22 | 1998-11-13 | Forbedret fremgangsmåde til stabilisering af proteiner |
Country Status (16)
Country | Link |
---|---|
US (1) | US6238664B1 (da) |
EP (1) | EP0917879B1 (da) |
JP (1) | JP3105494B2 (da) |
KR (1) | KR100315908B1 (da) |
CN (1) | CN1220270A (da) |
AR (2) | AR018020A1 (da) |
AT (1) | ATE220558T1 (da) |
AU (1) | AU714264B2 (da) |
BR (1) | BRPI9805021B8 (da) |
CA (1) | CA2254145C (da) |
DE (1) | DE59804785D1 (da) |
DK (1) | DK0917879T3 (da) |
ES (1) | ES2179414T3 (da) |
PT (1) | PT917879E (da) |
TR (1) | TR199802394A3 (da) |
ZA (1) | ZA9810650B (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US8632785B2 (en) * | 2000-02-08 | 2014-01-21 | Allergan, Inc. | Clostridial toxin pharmaceutical composition containing a gelatin fragment |
CN1258379C (zh) * | 2000-02-08 | 2006-06-07 | 阿勒根公司 | 肉毒杆菌毒素药物组合物 |
DE10149030A1 (de) * | 2001-10-05 | 2003-04-10 | Viscum Ag | Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin |
US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
US20030175827A1 (en) * | 2002-03-14 | 2003-09-18 | Stillman Brett A. | Stable thin film dried protein composition or device and related methods |
US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
EP1598074B1 (en) * | 2003-02-28 | 2019-01-02 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations |
JP2009502972A (ja) * | 2005-07-29 | 2009-01-29 | アムジエン・インコーポレーテツド | タンパク質凝集を抑制する製剤 |
CA2665423A1 (en) * | 2006-10-12 | 2008-04-17 | Wyeth | Methods and compositions with reduced opalescence |
KR20120027031A (ko) * | 2009-06-18 | 2012-03-20 | 와이어쓰 엘엘씨 | 소형 모듈 면역제약용 동결건조 제제 |
DK2892550T3 (da) | 2012-09-07 | 2020-03-30 | Coherus Biosciences Inc | Stabile vandige formuleringer af adalimumab |
EP3201319A4 (en) * | 2014-09-29 | 2018-05-16 | Cook General Biotechnology LLC | Uses of trehalose in cell suspensions |
US11229702B1 (en) | 2015-10-28 | 2022-01-25 | Coherus Biosciences, Inc. | High concentration formulations of adalimumab |
WO2017184880A1 (en) | 2016-04-20 | 2017-10-26 | Coherus Biosciences, Inc. | A method of filling a container with no headspace |
US11110063B2 (en) | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
CN111781345A (zh) * | 2020-06-30 | 2020-10-16 | 上海透景生命科技股份有限公司 | 化学发光标记物标记抗原稳定剂及其应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783441A (en) | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
DE3064888D1 (en) | 1979-04-30 | 1983-10-27 | Hoechst Ag | Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization |
US4362661A (en) | 1979-08-09 | 1982-12-07 | Teijin Limited | Immunoglobulin composition having a high monomer content, and process for production thereof |
CA1329760C (en) | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Plasma and recombinant protein formulations in high ionic strength media |
GB8726136D0 (en) * | 1987-11-07 | 1987-12-09 | Wellcome Found | Therapeutic nucleosides |
US4877608A (en) | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
DE3863908D1 (de) | 1987-11-27 | 1991-08-29 | Akzo Nv | Stabilisierung von antikoerpern. |
GB8920534D0 (en) * | 1989-09-11 | 1989-10-25 | Wellcome Found | Antiviral compounds |
US5164296A (en) * | 1990-08-31 | 1992-11-17 | University Of Maryland At Baltimore | Assay methods involving ouabain |
DE4126983A1 (de) * | 1991-08-15 | 1993-02-18 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke |
RU2109290C1 (ru) * | 1996-04-09 | 1998-04-20 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Стабилизирующий состав для получения лиофилизированных препаратов на основе конъюгата антииммуноглобулина g и пероксидазы хрена |
EP0852951A1 (de) * | 1996-11-19 | 1998-07-15 | Roche Diagnostics GmbH | Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern |
-
1998
- 1998-11-13 AT AT98121684T patent/ATE220558T1/de not_active IP Right Cessation
- 1998-11-13 PT PT98121684T patent/PT917879E/pt unknown
- 1998-11-13 DK DK98121684T patent/DK0917879T3/da active
- 1998-11-13 ES ES98121684T patent/ES2179414T3/es not_active Expired - Lifetime
- 1998-11-13 DE DE59804785T patent/DE59804785D1/de not_active Revoked
- 1998-11-13 EP EP98121684A patent/EP0917879B1/de not_active Revoked
- 1998-11-19 US US09/196,090 patent/US6238664B1/en not_active Expired - Lifetime
- 1998-11-20 CA CA002254145A patent/CA2254145C/en not_active Expired - Lifetime
- 1998-11-20 AR ARP980105921A patent/AR018020A1/es unknown
- 1998-11-20 TR TR1998/02394A patent/TR199802394A3/tr unknown
- 1998-11-20 CN CN98122531A patent/CN1220270A/zh active Pending
- 1998-11-20 KR KR1019980049921A patent/KR100315908B1/ko not_active IP Right Cessation
- 1998-11-20 AU AU94060/98A patent/AU714264B2/en not_active Expired
- 1998-11-20 ZA ZA9810650A patent/ZA9810650B/xx unknown
- 1998-11-23 BR BRPI9805021 patent/BRPI9805021B8/pt not_active IP Right Cessation
- 1998-11-24 JP JP10332681A patent/JP3105494B2/ja not_active Expired - Lifetime
-
2002
- 2002-05-09 AR ARP020101691A patent/AR034226A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE59804785D1 (de) | 2002-08-22 |
AU714264B2 (en) | 1999-12-23 |
EP0917879A2 (de) | 1999-05-26 |
AU9406098A (en) | 1999-06-10 |
KR100315908B1 (ko) | 2002-04-24 |
EP0917879B1 (de) | 2002-07-17 |
ES2179414T3 (es) | 2003-01-16 |
AR034226A2 (es) | 2004-02-04 |
KR19990045460A (ko) | 1999-06-25 |
JPH11240895A (ja) | 1999-09-07 |
BRPI9805021B1 (pt) | 2011-05-31 |
TR199802394A2 (xx) | 1999-06-21 |
CN1220270A (zh) | 1999-06-23 |
ATE220558T1 (de) | 2002-08-15 |
CA2254145C (en) | 2002-10-08 |
PT917879E (pt) | 2002-12-31 |
JP3105494B2 (ja) | 2000-10-30 |
AR018020A1 (es) | 2001-10-31 |
CA2254145A1 (en) | 1999-05-22 |
TR199802394A3 (tr) | 1999-06-21 |
EP0917879A3 (de) | 1999-06-09 |
BRPI9805021A (pt) | 2000-03-21 |
BRPI9805021B8 (pt) | 2021-07-06 |
US6238664B1 (en) | 2001-05-29 |
ZA9810650B (en) | 1999-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1011309T3 (da) | Fremgangsmåde til tilvejebringelse af forøget fotosyntese | |
FI971620A (fi) | Autentikointimenetelmä | |
DK0875252T3 (da) | Formuleringer af aktiveret protein C | |
DK0917879T3 (da) | Forbedret fremgangsmåde til stabilisering af proteiner | |
NO982097L (no) | Peptider | |
NO982098L (no) | Peptider | |
DE69830295D1 (de) | Steuerungsverfahren | |
NO2010022I1 (no) | Denosumab | |
DK0911416T3 (da) | Fremgangsmåde til fremstilling af protein | |
DE69839978D1 (de) | Fluorpolymerstabilisierung | |
ATE260674T1 (de) | Stabilisierte proteinzusammensetzung | |
DE69815975D1 (de) | Steuerungsverfahren | |
IS5106A (is) | Ný aðferð | |
DE69837784D1 (de) | Verbessertes fünf-fehler-korrektursystem | |
DK0987356T3 (da) | Fremgangsmåde til trækning | |
DE69816734D1 (de) | Steuerungsverfahren | |
DE69925271D1 (de) | Angiostatin-bindendes protein | |
TR199701666A3 (tr) | Sismanliga karsi proteinler | |
DK1524268T3 (da) | Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer | |
DE59711974D1 (de) | Routing-verfahren | |
PT1015447E (pt) | Derivado piperidinilmetiloxazolidinona | |
DE69837899D1 (de) | Elektrophoreseapparatur | |
ID19573A (id) | Herbisida selektif berbasiskan | |
FR2770103B1 (fr) | Bigoudi perfectionne | |
ATA195097A (de) | Korbartiger baustein |